In a recent commentary published on Medscape, Dr. Jha suggests that the debate over screening mammography should be about the financial costs per life saved rather than about the science of screening efficacy. SBI Board Member Jay Baker, MD, FSBI, explains why the science is incorrect in Dr. Jha's reasoning and why mammograms are crucial for detecting and curing early stage breast cancer.
TIME (3/7, Sifferlin) reports that research published in the Journal of Clinical Oncology “suggests that for certain women, double mastectomies – which are an increasingly popular choice for women with breast cancer – may not deliver the outcome some women expect.” Investigators studied approximately 4,000 women who underwent surgery for breast cancer.
SBI President Elizabeth A. Morris, MD, FSBI, explains why the Society of Breast Imaging created End the Confusion, a campaign to inform and engage providers, stakeholders, and the public on the benefits of breast cancer screening. “I have read patient mammograms that detected cancers early, when treatment is most effective. I have patients who are alive today because they followed the advice of respected organizations like the Society of Breast Imaging. Ultimately, this is the reason for End the Confusion; to save lives through early detection,” said Morris.
SBI Past President and ACR Breast Imaging Commission Chair, Debra Monticciolo, MD, FSBI, FACR, discusses the USPSTF breast screening recommendations.